Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes

Journal of Endocrinological Investigation

Volumn 37, Issue 7, 2014, Pages 661-666

  Maddaloni, Ernesto ^a   D'Onofrio, Luca ^a   Lauria, Angelo ^a   Maurizi, Anna Rita ^a   Strollo, Rocky ^a   Palermo, Andrea ^a   Napoli, Nicola ^a   Angeletti, Silvia ^a   Pozzilli, Paolo ^a,b   Manfrini, Silvia ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

BMI; HbA1c; Osteocalcin; Type 1 diabetes

Indexed keywords

25 HYDROXYVITAMIN D; C PEPTIDE; CREATININE; HEMOGLOBIN A1C; INSULIN; OSTEOCALCIN; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE METABOLISM; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETIC OSTEOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; ENERGY METABOLISM; FEMALE; FRACTURE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OSTEOBLAST; OSTEOPOROSIS; PHYSICAL EXAMINATION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BONE DISEASES, METABOLIC; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

EID: 84903738765     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0092-7     Document Type: Article

References (42)

1. International Diabetes Federation Guidelines (2011) Diabetes in childhood and adolescence
2. Gunczler P, Lanes R, Paz-Martinez V et al (1998) Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413-419 (Pubitemid 28317370)
3. Hoang QQ, Sicheri F, Howard AJ, Yang DSC (2003) Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425:977-980. doi:10.1038/nature02079 (Pubitemid 37376930)
4. Dowd TL, Rosen JF, Li L, Gundberg CM (2003) The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry 42:7769-7779. doi:10.1021/bi034470s (Pubitemid 36758942)
5. Hauschka PV, Carr SA (1982) Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry 21:2538-2547
6. Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270. doi:10.1073/pnas.0711119105 (Pubitemid 351738545)
7. Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469. doi:10.1016/j.cell.2007.05.047 (Pubitemid 47208519)
8. Kindblom JM, Ohlsson C, Ljunggren O et al (2009) Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 24:785-791. doi:10. 1359/jbmr.081234
9. Lee YJ, Lee H, Jee SH et al (2010) Serum osteocalcin is inversely associated with adipocyte-specific fatty acid-binding protein in the Korean metabolic syndrome research initiatives. Diabetes Care 33:e90. doi:10.2337/dc10-0071
10. Pittas AG, Harris SS, Eliades M et al (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827-832. doi:10.1210/jc.2008-1422
11. Saleem U, Mosley TH, Kullo IJ (2010) Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30:1474-1478. doi:10.1161/ATVBAHA.110. 204859
12. Hwang Y-C, Jeong I-K, Ahn KJ, Chung HY (2009) The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25:768-772. doi:10.1002/dmrr.1045
13. Kanazawa I, Yamaguchi T, Yamamoto M et al (2009) Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:45-49. doi:10.1210/jc.2008-1455
14. Im J-A, Yu B-P, Jeon JY, Kim S-H (2008) Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 396:66-69. doi:10.1016/j.cca.2008.07.001
15. Bao Y-Q, Zhou M, Zhou J et al (2011) Relationship between serum osteocalcin and glycaemic variability in type 2 diabetes. Clin Exp Pharmacol Physiol 38:50-54. doi:10.1111/j.1440-1681. 2010.05463.x
16. Prats-Puig A, Mas-Parareda M, Riera-Pérez E et al (2010) Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 33:661-663. doi:10.2337/dc09-1837
17. Pollock NK, Bernard PJ, Wenger K et al (2010) Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res 25:2760-2769. doi:10.1002/jbmr.184
18. Maggio ABR, Ferrari S, Kraenzlin M et al (2010) Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab 23:697-707
19. Pater A, Sypniewska G, Pilecki O (2010) Biochemical markers of bone cell activity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 23:81-86
20. Thrailkill KM, Jo C-H, Cockrell GE et al (2012) Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int 23:1799-1806. doi:10.1007/s00198-011-1807-7
21. Napoli N, Strollo R, Pitocco D et al (2013) Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. PLoS One 8:e56488. doi:10.1371/journal.pone.0056488
22. Motyl KJ, McCabe LR, Schwartz AV (2010) Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 503:2-10. doi:10.1016/j.abb.2010.07.030
23. Hofbauer LC, Brueck CC, Singh SK, Dobnig H (2007) Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22:1317-1328. doi:10.1359/jbmr.070510 (Pubitemid 351339677)
24. Ma L, Oei L, Jiang L et al (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27:319-332. doi:10.1007/s10654-012-9674-x
25. Melton LJ, Riggs BL, Leibson CL et al (2008) A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 93:4804-4809. doi:10.1210/jc.2008-0639
26. Burghardt AJ, Issever AS, Schwartz AV et al (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:5045-5055. doi:10.1210/jc.2010-0226
27. Hadjidakis DJ, Raptis AE, Sfakianakis M et al (2006) Bone mineral density of both genders in type 1 diabetes according to bone composition. J Diabetes Complicat 20:302-307. doi:10.1016/j.jdiacomp.2005.07.006 (Pubitemid 44308584)
28. McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem102:1343-1357. doi:10.1002/jcb.21573
29. Goh S-Y, Cooper ME (2008) Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93:1143-1152. doi:10.1210/jc.2007-1817 (Pubitemid 351519698)
30. Räkel A, Sheehy O, Rahme E, LeLorier J (2008) Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 34:193-205. doi:10.1016/j.diabet.2007.10.008
31. Conover CA, Lee PD, Riggs BL, Powell DR (1996) Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 137:3295-3301 (Pubitemid 26250178)
32. Thrailkill KM, Lumpkin CK, Bunn RC et al (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735-E745. doi:10.1152/ajpendo.00159.2005 (Pubitemid 41504371)
33. Pozzilli P, Manfrini S, Crinò A et al (2005) Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res 37:680-683. doi:10.1055/s-2005-870578 (Pubitemid 41810490)
34. Pitocco D, Crinò A, Di Stasio E et al (2006) The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset type 1 diabetes (IMDIAB XI). Diabet Med 23:920-923. doi:10.1111/j.1464-5491.2006.01921.x (Pubitemid 44141083)
35. Bizzarri C, Pitocco D, Napoli N et al (2010) No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care 33:1962-1963. doi:10.2337/dc10-0814
36. Kanazawa I, Yamaguchi T, Yamauchi M et al (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22:187-194. doi:10.1007/s00198-010- 1184-7
37. Iki M, Tamaki J, Fujita Y et al (2012) Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Osteoporos Int 23:761-770. doi:10.1007/s00198-011- 1600-7
38. Ducy P (2011) The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54:1291-1297. doi:10.1007/s00125-011-2155-z
39. Gerdhem P, Isaksson A, Akesson K, Obrant KJ (2005) Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512. doi:10.1007/s00198-005-1877-5 (Pubitemid 41790853)
40. Chillaro JJ, Goday A, Flores-le-roux JA et al (2009) Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab 94:3530-3534. doi:10.1210/jc.2009-0960
41. Ferron M, Wei J, Yoshizawa T et al (2010) An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun 397:691-696. doi:10.1016/j.bbrc.2010.06.008
42. Ferron M, Wei J, Yoshizawa T et al (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296-308. doi:10.1016/j.cell.2010.06.003